arrow
J

Jennifer E. Amengual

washington university (wustl)
H指数:24
被引数:2,267

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma

伊匹木单抗、纳武利尤单抗和 Brentuximab Vedotin 治疗复发霍奇金淋巴瘤的随机二期研究

Blood
IF23.1
2026-04-011
PRE
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

美国多中心回顾性研究:浆细胞样淋巴瘤的预后与治疗

2026-03-230
OAAI
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
2023-12-135
OAAI